|
Volumn 579, Issue 4 SPEC. ISS., 2005, Pages 892-894
|
Towards therapeutic applications of engineered zinc finger proteins
|
Author keywords
Gene correction; Gene regulation; Zinc fingers
|
Indexed keywords
DNA BINDING PROTEIN;
VASCULOTROPIN;
ZINC FINGER PROTEIN;
HYBRID PROTEIN;
TRANSCRIPTION FACTOR;
ANGIOGENESIS;
ARTERY DISEASE;
CLAUDICATION;
COMBINED IMMUNODEFICIENCY;
CONFERENCE PAPER;
DNA PROTEIN COMPLEX;
DNA SEQUENCE;
DRUG EFFECT;
GAUCHER DISEASE;
GENE ACTIVATION;
GENE CONVERSION;
GENE DELETION;
GENE EXPRESSION REGULATION;
GENE FUNCTION;
GENE REPRESSION;
GENE TARGETING;
GENE THERAPY;
HEMOPHILIA;
HOMOLOGOUS RECOMBINATION;
HUMAN;
MONOGENIC DISORDER;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN ENGINEERING;
PROTEIN RNA BINDING;
SICKLE CELL ANEMIA;
ANIMAL;
CARDIOVASCULAR DISEASE;
GENETIC DISORDER;
GENETIC RECOMBINATION;
GENETICS;
METABOLISM;
PHYSIOLOGY;
REVIEW;
ANIMALIA;
ANIMALS;
CARDIOVASCULAR DISEASES;
DNA-BINDING PROTEINS;
GENE EXPRESSION REGULATION;
GENETIC DISEASES, INBORN;
HUMANS;
PROTEIN ENGINEERING;
RECOMBINANT FUSION PROTEINS;
RECOMBINATION, GENETIC;
TRANSCRIPTION FACTORS;
ZINC FINGERS;
|
EID: 14544301097
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/j.febslet.2004.10.104 Document Type: Conference Paper |
Times cited : (67)
|
References (16)
|